|
|
4th
Edition - Athens, Greece-October 26-28, 2007
|
OCTOBER 26 |
|
18:00 |
Networking Reception |
|
OCTOBER 27 |
|
8:00 |
Robert Friedland,
MD,
Professor, Case Western Reserve University,
Cleveland, USA; Spiros Efthimiopoulos,
PhD,
Assistant Professor, University of Athens, Athens,
Greece,
and Paraskevi Sakka, MD, President of the
Athens Alzheimer’s Association |
Welcome Notes |
|
8:05 |
Marc Wortmann, Executive Director,
Alzheimer’s Disease International, London, UK |
Dementia, A Global Issue |
|
8:25 |
Nikos Robakis, MD, Professor, Mount Sinai
School of Medicine, New York, USA |
Molecular Pathology and Novel Therapies for
Alzheimer’s disease |
|
TREATMENT |
|
9:10 |
Menelaos Pangalos, MD, Vice President,
Neuroscience Research, Wyeth, Princeton, USA |
Novel approaches for the treatment of Alzheimer's
disease: Improved Symptomatics and Beyond |
|
9:30 |
Marwan Sabbagh,
MD,
Founding director of the Cleo Roberts Center for
Clinical Research, Sun Health Institute, Arizona,
USA |
Future Treatments of Alzheimer's Disease |
|
9:50 |
Break |
|
|
BEHAVIORAL/PSYCHIATRIC ISSUES |
|
10:10 |
Diana Paleacu, MD, Ness Ziona Mental Health,
and Rehabilitation Center, Medical School, Tel Aviv,
Israel |
How Do the Leisure Activities Influence the
Cognitive Function in an Elderly Nursing Home
Population |
|
10:30 |
Rivka Inzelberg, MD, Professor, Technicon
Rappoport School of Medicine, Haifa, Israel |
Neuropsychiatric Disturbances in Parkinson's Disease |
|
10:50 |
Magda Tsolaki,
MD,
Professor, Aristotle University of Thessaloniki,
Thessaloniki, Greece |
Post Traumatic Stress Dementia: a Proposed Model of
Neurodegeneration and its Implications for
Prevention |
|
11:10 |
Larry Sparks,
PhD,
Head and Senior Scientist, Sun Health Research
Institute, Sun City, AZ, USA |
Cholesterol and the Etiopathogenesis and Treatment
of Alzheimer’s Disease |
|
11:30 |
Abeer Mahmoud Eissa,
PhD,
Lecturer of Psychiatry, Institute of Psychiatry-
Faculty of Medicine –Ain Shams, Egypt |
Towards more objective Differentiation Between
Pseudodementia and Dementia |
|
11:50 |
Lunch |
|
|
MOLECULAR BASIS OF DISEASE |
|
13:30 |
Spiros Efthimiopoulos,
PhD,
Assistant Professor, University of Athens, Athens,
Greece |
Neurodegenerative Diseases: Similarities in
Pathology Suggest Common Molecular Mechanisms
Leading to Neuronal Death |
|
13:50 |
Robert Friedland,
MD,
Professor, Case Western Reserve University,
Cleveland, OH, USA |
Immunology of the A-Beta Protein and AD Risk |
|
14:10 |
Larry Sparks,
PhD,
Head and Senior Scientist, Sun Health Research
Institute, Sun City, AZ, USA |
Cholesterol and the Etiopathogenesis and Treatment
of Alzheimer’s Disease |
|
14:30 |
Spiros Georgopoulos, PhD, Center for
Transplantation, Institute for Biomedical Research,
Academy of Athens, Athens, Greece |
ApoE, Cholesterol and Alzheimer’s Disease in
Transgenic Mouse Models |
|
14:50 |
Changiz Geula, PhD, Professor of
Neuroscience, Cognitive Neurology and Alzheimer’s
Disease Center, Northwestern University, Feinberg
School of Medicine, Chicago, USA |
Early and Selective Vulnerability of the Basal
Forebrain Cholinergic System in Aging and
Alzheimer's Disease: Controversy and Resolution |
|
15:10 |
Athina Tzinia, PhD, Institute of Biology,
NCSR "Demokritos" |
Matrix Metalloproteinase B (MMP-9) Possesses
α-Secretase-Like Activity and Associates with APP on
Cell Surface |
|
15:30 |
Break |
|
|
15:50 |
Dido Vasilakopoulou,
PhD,
Assistant Professor - University of Athens, Dept.
Biology, Division of Molecular Biology and
Biochemistry, Athens, Greece |
New Data Concerning the Functional Significance of
L-DOPA Decarboxylase |
|
16:10 |
Demetrios K. Vassilatis, PhD, Department of
Cell Biology, Centre of Basic Research, Foundation
for Biomedical Research, Academy of Athens |
Parkinson's Disease and NR4A2 Mediated
Neuroprotection: a Working Hypothesis |
|
16:30 |
Kostas Vekrelis, PhD, Centre of Basic
Research, Foundation for Biomedical Research,
Academy of Athens |
Effects of Oligomers on Cell Homeostasis: Lessons
from Alpha-synuclein |
|
16:50 |
Antonios Politis, PhD,
University of Athens, Deprt. Of Psychiatry, Division
of Old age Psychiatry, Eginition Hospital, Athens,
Greece |
Cytokine Release in Alzheimer's Disease |
|
18:30 |
GALA DINNER |
|
OCTOBER 28 |
|
8:30 |
Georgios Hadjigeorgiou,
PhD,
University of Thessaly, Medical School,Thessaly,
Greece |
Oxidative Stress and Alzheimer’s Disease |
|
DIAGNOSIS AND CLINICAL FEATURES |
|
8:50 |
Elisabeth Kapaki, MD, Department of
Neurology, 'Aeginition' Hospital, Athens, Greece |
Biological Markers for Dementia Clinic and
Differential Diagnosis |
|
9:10 |
Marwan Ramadan, MD, Chief of Geriatrics,
Hamad Medical Center, Doha, Qatar |
Dementia in Qatar |
|
9:30 |
Sokratis Papageorgiou, PhD, Lecturer Eginitio
Hospital University of Athens, Athens, Greece |
Role of Imaging in the Evaluation of Dementia |
|
9:50 |
Break |
|
10:10 |
Klimentini Karageorgiou, MD, Director of the
Neurology Department, Gennimatas Hospital, Athens,
Greece |
Current and Future Treatment in Dementia |
|
10:30 |
John Papatriantafylou, MD, Neurology
Department, Gennimatas Hospital, Athens, Greece |
Frontotemporal Dementia Across Three Continents |
|
10:50 |
Eman Al-Khateeb, MD, Professor, Faculty of
Medicine, University of Jordan, Amman, Jordan |
The Predictive Value of Carotid Doppler In Vascular
Changes Underlying Cognitive Impairment in Middle
Aged and Elderly Iraqis |
|
11:10 |
Stavros J. Baloyannis, MD, Professor of
Neurology, Department of Neurology, Aristotelian
University Thessaloniki, Greece |
The Visual Cortex in Alzheimer's Disease |
|
11:30 |
E.B. Mukaetova-Ladinska, Institute for Ageing
and Health, Newcastle University, Newcastle, United
Kingdom |
How Diet Influences Cognition |
|
11:50 |
Lunch |
|
GENETICS |
|
13:00 |
Efthimios Skoulakis, PhD, Institute of
Molecular Biology and Genetics, BSRC Alexander
Fleming, Vari, Greece |
Tau Isotype Specific Pathology and Molecular
Interactions; Modeling Tauopathies in Drosophila |
|
13:20 |
Makrelouf M.,
PhD,
Genetic Biochemistry Laboratory, BAB-EL-OUED
University Hospital, Algiers - Algeria |
Association Of Apolipoprotein E Genotypes And
Hyperhomocysteinemia With Dementia Among Algerian
Population |
|
13:40 |
Doaa Hamed Moustafa Hewedi, PhD, Ain-Shams
University - Institute of Psychiatry, Cairo, Egypt |
Immunophenotypical Alteration of CD45 Qualitative
Expression as an Early Diagnostic Marker of
Alzheimer's Disease |
|
CAREGIVING AND PUBLIC POLICY |
|
14:00 |
Paraskevi Sakka, MD, President of the Athens
Alzheimer’s Association, Athens, Greece |
Dementia Status in Greece: After the Diagnosis What? |
|
14:20 |
Ruth Goldberg, Chair, Alzheimer’s Association
of Israel, Tel Aviv, Israel |
How to Raise Awareness and Make Dementia a National
Health Care Priority |
|
14:40 |
Abdelmoneim Ashour, Ain-Shams University,
Institute of Psychiatry, Cairo, Egypt |
Needs Assessment for Care of Early Dementia Cases in
Egypt |
|
15:00 |
Waleed Fawzi,
MD,
King's College Londo, London,
UK |
Health Beliefs and Dementia In Egypt |
|
15:20 |
Break |
|
|
15:40 |
Nasser Loza, MD, Medical Director, Behman
Hospital, Cairo, Egypt |
The Burden of Dementia in an Extended Family Social
Network - a Historical Perspective |
|
16:00 |
Diane Mansour, Executive Director,
Alzheimer’s Association Lebanon, Beirut |
The Importance of Establishing Alzheimer's
Associations in the Arab Countries |
|
16:20 |
Chris Messis, MD, President, Mediterranean
Neurological Society, Cyprus |
Ethical and Legal Issues in the Care of Alzheimer's
Patients in Cyprus |
|
16:40 |
Closing Notes |
Robert Friedland and Spiros Efthymiopoulos |
TOP
|
Convener:
Robert P.
Friedland, MD,
Professor, Case Western Reserve University
Chair, Local Organizing Committee:
Spiros
Efthymiopoulos, PhD
Assistant Professor, University of Athens
SUPPORTERS
Jansen Hellas
PLATINUM SPONSOR
Pfizer USA
PLATINUM SPONSOR
Wyeth USA
PLATINUM SPONSOR
Athens Society for Alzheimer's Disease
GOLD
SPONSOR
Gerolymatos
GOLD
SPONSOR
Wyeth Hellas
GOLD
SPONSOR
Pfizer Hellas
GOLD
SPONSOR
Novartis
Hellas
SILVER
SPONSOR
Lunbeck
Hellas
SILVER
SPONSOR
ALZHEIMER’S ASSOCIATION USA
SCHOLARSHIP SPONSOR
Noldus
Information Technology
EXHIBITOR
AND ADVERTISER
TOP
|
